Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia

被引:0
|
作者
Dikshat Gopal Gupta
Neelam Varma
Sarki Abba Abdulkadir
Parmod Singh
Man Updesh Singh Sachdeva
Shano Naseem
Mohammad Rizwan Siddiqui
Parveen Bose
Jogeshwar Binota
Pankaj Malhotra
Alka Khadwal
Subhash Varma
机构
[1] Robert H. Lurie Comprehensive Cancer Center,Department of Urology
[2] Feinberg School of Medicine,Department of Hematology
[3] Post Graduate Institute of Medical Education and Research,Department of Anatomy
[4] Post Graduate Institute of Medical Education and Research,Department of Pediatrics
[5] Ann and Robert H. Lurie Children’s Hospital of Chicago,Department of Clinical Hematology and Medical Oncology
[6] Post Graduate Institute of Medical Education and Research,Department of Internal Medicine
[7] Post Graduate Institute of Medical Education and Research,undefined
来源
关键词
B-acute lymphoblastic leukemia (B-ALL); Gene expression profiling (GEP); Housekeeping genes (HKG); High-risk ALLs; Real-time quantitative PCR (RQ-PCR);
D O I
暂无
中图分类号
学科分类号
摘要
Gene expression profiling is the criterion standard for recognizing Ph-like ALL signatures among B-ALLs. The prerequisite of GEP is the accurate normalization of target genes with stable expression of housekeeping genes in a quantitative PCR. HKGs exhibit differential expression in the different experimental conditions and affect the target genes' expression, leading to imprecise qPCR results. The selection of stable HKGs is crucial in GEP experiments, especially in identifying high-risk Ph-like ALL cases. We have evaluated the expression stability of nine HKGs (GAPDH, ACTB, GUSB, RNA18S, EEF2, PGK1, B2M, TBP and ABL1) in identified Ph-like ALLs and Ph-negative (n = 23 each) using six algorithms, 4 traditional softwares; geNorm, BestKeeper, NormFinder, Delta Cq value method, and two algorithms, RefFinderTM and ComprFinder. Further, we have validated the expression of 8 overexpressed normalized genes in Ph-like ALL cases (JCHAIN, CA6, MUC4, SPATS2L, BMPR1B, CRLF2, ADGRF1 and NRXN3). GeNorm, BestKeeper, NormFinder, Delta Cq value method, RefFinderTM and ComprFinder algorithm analysis revealed that EEF2, GAPDH, and PGK1 form the best representative HKGs in Ph-like ALL cases, while RNA18s, ß-actin, and ABL1 in Ph-negative ALLs. Lastly, we performed a correlation analysis and found that the combination of EEF2, GAPDH, and PGK1 represents the best combination with a very high correlation in Ph-like ALL cases. This is the first report that shows EEF2, GAPDH, and PGK1 are the best HKG genes and can be used in the diagnostic panel of Ph-like ALL cases using qPCR at baseline diagnosis.
引用
收藏
页码:4539 / 4551
页数:12
相关论文
共 46 条
  • [31] Pre-Clinical Efficacy of the Novel Kinase Inhibitor Nintedanib on PAX5 Fusion Genes in Pediatric Ph-like B-Cell Precursor Acute Lymphoblastic Leukemia
    Fazio, Grazia
    Bresolin, Silvia
    Saitta, Claudia
    Silvestri, Daniela
    Vendramini, Elena
    Palmi, Chiara
    Rigamonti, Silvia
    Galbiati, Marta
    Quadri, Manuel
    Mecca, Stefano
    Savino, Angela Maria
    Bardini, Michela
    Grioni, Andrea
    Valsecchi, Maria Grazia
    te Kronnie, Geertruy
    Biondi, Andrea
    Cazzaniga, Giovanni
    BLOOD, 2019, 134
  • [32] Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like ("Ph-like" or "BCR-ABL1-Like") Signature For Therapeutic Targeting and Clinical Intervention
    Harvey, Richard C.
    Kang, Huining
    Roberts, Kathryn G.
    Chen, I-Ming L.
    Atlas, Susan R.
    Bedrick, Edward J.
    Gastier-Foster, Julie M.
    Zhang, Jinghui
    Gerhard, Daniels S.
    Smith, Malcolm A.
    Larsen, Eric C.
    Raetz, Elizabeth A.
    Winick, Naomi J.
    Carroll, William L.
    Stonerock, Eileen
    Heerema, Nyla A.
    Carroll, Andrew J.
    Chen, Shann-Ching
    Song, Guangchun
    Becksfort, Jared
    Rusch, Michael
    Li, Yongjin
    Ma, Jing
    Ell, Denise
    Reshmi, Shalini C.
    Loh, Mignon L.
    Davidas, Meenakshi
    Hunger, Stephen P.
    Mullighan, Charles G.
    Willman, Cheryl L.
    BLOOD, 2013, 122 (21)
  • [33] Frequency of actionable gene fusions in patients with Philadelphia chromosome-like (Ph-like) B-acute lymphoblastic leukemia (ALL): A retrospective study from the Children's Oncology Group (COG)
    Reshmi, Shalini C.
    Harvey, Richard C.
    Smith, Amy
    Chen, I-Ming
    Valentine, Marc
    Liu, Yu
    Li, Yongjin
    Zhang, Jinghui
    Roberts, Kathryn G.
    Shao, Ying
    Easton, John
    Payne-Turner, Debbie
    Devidas, Meenakshi
    Heerema, Nyla
    Carroll, Andrew J.
    Raetz, Elizabeth A.
    Borowitz, Michael J.
    Wood, Brent L.
    Angiolillo, Anne L.
    Burke, Michael M.
    Salzer, Wanda L.
    Zweidler-McKay, Patrick A.
    Rabin, Karen R.
    Carroll, William L.
    Loh, Mignon L.
    Hunger, Stephen P.
    Mullighan, Charles G.
    Willman, Cheryl L.
    Gastier-Foster, Julie M.
    CANCER RESEARCH, 2015, 75
  • [34] Detection of a novel SNX2 gene breakpoint in the SNX2::ABL1 fusion transcript in Ph-like B-cell acute lymphoblastic leukemia
    Leons, Gadha K. K.
    Sharma, Preity
    Gupta, Sanjeev Kumar
    Gupta, Ritu
    Rani, Lata
    Gajendra, Smeeta
    Roy, Anita
    Sahoo, Ranjit Kumar
    PEDIATRIC BLOOD & CANCER, 2023, 70 (10)
  • [35] RECOMBINATION ACTIVATING GENE-1 (RAG-1) IS EXPRESSED IN ALL STAGES OF B-LINEAGE PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PRIOR TO SURFACE IG EXPRESSION
    UMIEL, T
    PATTENGALE, P
    WEINBERG, K
    FASEB JOURNAL, 1992, 6 (05): : A1706 - A1706
  • [36] IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA
    Kuelp, Marius
    Larghero, Patrizia
    Alten, Julia
    Cario, Gunnar
    Eckert, Cornelia
    Caye-Eude, Aurelie
    Cave, Helene
    Schmachter, Tessa
    Bardini, Michela
    Cazzaniga, Giovanni
    De Lorenzo, Paola
    Valsecchi, Maria Grazia
    Bonig, Halyard
    Meyer, Claus
    Riegeri, Michael
    Marschalek, Rolf
    EXPERIMENTAL HEMATOLOGY, 2023, 124 : S104 - S104
  • [37] MOLECULAR CYTOGENETICS OF ETV6/RUNX1 GENE FUSION AND OTHER ABNORMALITIES INVOLVING ETV6 AND RUNX1 GENES IN PEDIATRIC B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA
    Salem, S. I.
    El-Rahman, M. Abd
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 492 - 493
  • [38] B-Cell Acute Lymphoblastic Leukemia (B-ALL) Subtype Classification by RNA Sequencing (RNA-Seq) Gene Expression Profiling is Suitable for Clinical Diagnostic Use
    Schmidt, R.
    Yellapantula, V.
    Kovach, A.
    Miller, K.
    Ji, J.
    Doan, A.
    Bhojwani, D.
    Raca, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S36 - S37
  • [39] Role of the DNA Repair Machinery in Childhood B-Lineage Acute Lymphoblastic Leukemia: Aberrations of NBS1, Fancd2, Palb2 Genes and Expression of BRCA1 and BRCA2
    Lo Nigro, Luca
    La Cognata, Daria
    Andriano, Nellina
    Cannata, Emanuela
    La Rosa, Manuela
    Arrabito, Marta
    Russo, Giovanna
    BLOOD, 2023, 142
  • [40] DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers
    F J T Staal
    M van der Burg
    L F A Wessels
    B H Barendregt
    M R M Baert
    C M M van den Burg
    C Van Huffel
    A W Langerak
    V H J van der Velden
    M J T Reinders
    J J M van Dongen
    Leukemia, 2003, 17 : 1324 - 1332